Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 77 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DP2DA051912
NIBIB U54
Grant: EB027049
NIBIB NIH HHS
Grant: U54 EB027049
Health and Care Research Wales
Grant: HS-22-32
NIAID NIH HHS
Grant: R01 AI150672
Medical Research Council
Grant: MR/S00971X/1
National Institutes of Health
Grant: 5U54EB027049-05
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
National Institutes of Health
Grant: 3DP2DA051912-01S2
Interferon-modulated vaccines against HIV
FWCI
7.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals